Windtree Therapeutics has not been…
Windtree Therapeutics has not been shy about its desire to [...]
William Blair has hand-picked its…
William Blair has hand-picked its top five stock recommendations for [...]
Hope Biosciences has linked its…
Hope Biosciences has linked its stem cell therapy candidate to [...]
Despite a year of trade tensions,…
Despite a year of trade tensions, national security strictures and [...]
Six people, including a former…
Six people, including a former employee of investment bank Citigroup’s [...]
Amid news of the splashy $4.8…
Amid news of the splashy $4.8 billion Amicus buy, BioMarin [...]
Two years after Gilead secured the…
Two years after Gilead secured the first option on Assembly [...]
Boehringer Ingelheim has opened…
Boehringer Ingelheim has opened another front in its attack on [...]
Big Pharma-backed Aktis Oncology…
Big Pharma-backed Aktis Oncology has announced plans to go public [...]
Having kicked off the year with a…
Having kicked off the year with a $200 million series [...]